Jane Street
VNDA icon

Jane Street’s Vanda Pharmaceuticals VNDA Stock Holding History

Jane Street’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,100
Closed -$413K – 10857
2021
Q3 		$413K Buy
24,100
+11,600
+93% +$203K ﹤0.01% 7629
2021
Q2 		$269K Buy
+12,500
New +$224K ﹤0.01% 8343
2018
Q2 		– Sell
-17,400
Closed -$293K – 5671
2018
Q1 		$293K Buy
+17,400
New +$291K ﹤0.01% 4051

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's VNDA Position: Q1 2026 in Review

Jane Street increased its Vanda Pharmaceuticals (VNDA) stake by 324% in Q1 2026, buying an estimated $1.24M and bringing the position to 210,243 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #5707.

Jane Street first reported a position in VNDA in Q1 2014 and has held it in 26 quarters since. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Jane Street held 210,243 shares of Vanda Pharmaceuticals worth $1.45M as of Q1 2026.
  • Jane Street bought 160,602 Vanda Pharmaceuticals shares in Q1 2026, an estimated $1.24M.
  • Vanda Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5707 holding.
  • Jane Street first reported a position in Vanda Pharmaceuticals in Q1 2014 and has held it in 26 quarters since.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.